These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11386793)

  • 21. The treatment of depression in patients with advanced cancer undergoing palliative care.
    Price A; Hotopf M
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):61-6. PubMed ID: 19365163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Depression in the medically ill: diagnosis and treatment considerations in C-L psychiatry settings].
    Rothenhäusler HB; Kapfhammer HP
    Fortschr Neurol Psychiatr; 2003 Jul; 71(7):358-65. PubMed ID: 12858256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of depression and antidepressant use in an otolaryngology patient population.
    Chandra RK; Epstein VA; Fishman AJ
    Otolaryngol Head Neck Surg; 2009 Jul; 141(1):136-8. PubMed ID: 19559973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in depression associated with neurologic illness: clinical correlates and pharmacologic response.
    Okiishi CG; Paradiso S; Robinson RG
    J Gend Specif Med; 2001; 4(2):65-72. PubMed ID: 11480103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment.
    Ekinci O; Titus JB; Rodopman AA; Berkem M; Trevathan E
    Epilepsy Behav; 2009 Jan; 14(1):8-18. PubMed ID: 18804186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.
    Banach M; Popławska M; Błaszczyk B; Borowicz KK; Czuczwar SJ
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1067-80. PubMed ID: 27267259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant-elicited changes in gene expression: remodeling of neuronal circuits as a new hypothesis for drug efficacy.
    Yamada M; Yamada M; Higuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):999-1009. PubMed ID: 15975701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for psychogenic nonepileptic seizures in children and adolescents with epilepsy.
    Vincentiis S; Valente KD; Thomé-Souza S; Kuczinsky E; Fiore LA; Negrão N
    Epilepsy Behav; 2006 Feb; 8(1):294-8. PubMed ID: 16253566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy.
    Cramer JA; Blum D; Fanning K; Reed M;
    Epilepsy Behav; 2004 Jun; 5(3):337-42. PubMed ID: 15145303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target.
    Lader M
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):743-55. PubMed ID: 17624740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
    Arantes-Gonçalves F; Coelho R
    Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review.
    Morishita S
    Hum Psychopharmacol; 2009 Apr; 24(3):191-8. PubMed ID: 19330803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of psychotropic drugs in epilepsy: what every neurologist should know.
    Kanner AM
    Semin Neurol; 2008 Jul; 28(3):379-88. PubMed ID: 18777484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression in women--issues in evaluation and management.
    Chandra PS; Babu SB
    J Indian Med Assoc; 2000 May; 98(5):237-41, 244, 249. PubMed ID: 11002622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological treatment of unipolar depression.
    Anderson IM
    Curr Top Behav Neurosci; 2013; 14():263-89. PubMed ID: 22544348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research and treatment approaches to depression.
    Wong ML; Licinio J
    Nat Rev Neurosci; 2001 May; 2(5):343-51. PubMed ID: 11331918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent depression: description, causes, and interventions.
    Hankin BL
    Epilepsy Behav; 2006 Feb; 8(1):102-14. PubMed ID: 16356779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression in epilepsy: a critical review from a clinical perspective.
    Hoppe C; Elger CE
    Nat Rev Neurol; 2011 Jul; 7(8):462-72. PubMed ID: 21750525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressant drugs: indications and guidelines for use in epilepsy.
    Schmitz B
    Epilepsia; 2002; 43 Suppl 2():14-8. PubMed ID: 11903477
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rating of antidepressant activity (author's transl)].
    Hamilton M
    Encephale; 1979; 5(5 Suppl):651-4. PubMed ID: 548278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.